A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America

International Journal of Clinical Practice

Volumn 64, Issue 9, 2010, Pages 1301-1309

  Xochilcal Morales, M ^a   Castro, E M ^b   Guajardo Rosas, J ^c   Obregon T N ^d   Acevedo, J C ^e   Chucan, J M G ^f   Plancarte Sanchez, R ^c   Davila, G ^g   Wajsbrot, D ^g   Guerrero, M ^g   Vinueza, R ^h  

^a Centro de Investigacion Clinica Del Pacifico   (Mexico)

^b HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^e Asociacion Medica de Los Andes   (Colombia)

^f Medicina Fetal Peru Fetal Medicine Unit at Clínica Internacional and Clinica Anglo Americana   (Peru)

^g PFIZER INC   (United States)

^h InterAmerican Foundation for Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL; ENALAPRIL; GLIBENCLAMIDE; INSULIN; METFORMIN; PARACETAMOL; PREGABALIN; RANITIDINE; TRAMADOL;

ADULT; AGED; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DAILY PAIN RATING SCALE; DIABETIC NEUROPATHY; DISORIENTATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSURIA; EDEMA; FEMALE; GASTRITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPATHIC PAIN; PAIN; PATIENT SATISFACTION; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RATING SCALE; RECTUM HEMORRHAGE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WEIGHT GAIN; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; COLOMBIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ECUADOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MEXICO; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PERU; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENEZUELA; YOUNG ADULT;

EID: 77954640195     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02389.x     Document Type: Article

References (24)

1. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 2002 18 : 343 349.
2. Gore M, Brandenburg NA, Hoffman DL et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006 7 : 892 900. (Pubitemid 44854739)
3. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002 18 : 350 354.
4. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009 27 : 95 112.
5. Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006 13 : 1153 1169.
6. Dubinsky RM, Kabbani H, El-Chami Z et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004 63 : 959 965.
7. Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007 12 : 13 21.
8. 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007 73 : 137 150.
9. Stacey BR, Swift JN. Pregabalin for neuropathic pain based on recent clinical trials. Curr Pain Headache Rep 2006 10 : 179 184.
10. Dworkin RH, Corbin AE, Young JP Jr. et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003 60 : 1274 1283.
11. Freynhagen R, Strojek K, Griesing T et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005 115 : 254 263.
12. Sabatowski R, Galvez R, Cherry DA et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004 109 : 26 35.
13. van Seventer R, Feister HA, Young JP Jr. et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006 22 : 375 384.
14. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004 63 : 2104 2110.
15. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004 110 : 628 638.
16. Richter RW, Portenoy R, Sharma U et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005 6 : 253 260.
17. Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 2008 8 : 33.
18. Tölle T, Freynhagen R, Versavel M et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain 2008 12 : 203 213.
19. Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract 2009 9 : 35 42.
20. Vondracek P, Oslejskova H, Kepak T et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol 2009 13 : 332 336.
21. Stacey BR, Dworkin RH, Murphy K et al. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial. Pain Med 2008 9 : 1202 1208.
22. Freynhagen R, Grond S, Schupfer G et al. Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. Int J Clin Pract 2007 61 : 1989 1996.
23. Tarride JE, Gordon A, Vera-Llonch M et al. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther 2006 28 : 1922 1934.
24. Rodríguez MJ, Díaz S, Vera-Llonch M et al. Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. Curr Med Res Opin 2007 23 : 2585 2596.